| Margaret Elizabeth Speeker-cruit, MD | |
|
1717 N E St, Suite 430, Pensacola, FL 32501-6339 | |
| (850) 437-8711 | |
| Not Available |
| Full Name | Margaret Elizabeth Speeker-cruit |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 22 Years |
| Location | 1717 N E St, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972700565 | NPI | - | NPPES |
| 001946700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME 106089 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Hospital | Pensacola, FL | Hospital |
| Gulf Breeze Hospital | Gulf breeze, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Medical Group Llc | 9638215734 | 220 |
| Baptist Medical Group Llc | 9638215734 | 220 |
News Archive
Next milestone in the development of bionic arm prostheses with major contribution from the Medical University of Vienna: in collaboration with the Massachusetts Institute of Technology (Center for Extreme Bionics) and the Department of Electrical Engineering at the University of Gothenburg, Oskar Aszmann's team in the Clinical Laboratory for Bionic Limb Reconstruction at MedUni Vienna's Department of Surgery has developed the world's first fully integrated bionic arm prosthesis that is ready to use - in keeping with the motto "Plug and Play".
In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
The World Health Organization (WHO) is attempting to clarify from China, reports that the government there encouraged farmers to use a human anti-viral drug to treat birds infected with a deadly strain of avian flu.
› Verified 7 days ago
| Entity Name | Baptist Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376779892 PECOS PAC ID: 9638215734 Enrollment ID: O20091002000436 |
News Archive
Next milestone in the development of bionic arm prostheses with major contribution from the Medical University of Vienna: in collaboration with the Massachusetts Institute of Technology (Center for Extreme Bionics) and the Department of Electrical Engineering at the University of Gothenburg, Oskar Aszmann's team in the Clinical Laboratory for Bionic Limb Reconstruction at MedUni Vienna's Department of Surgery has developed the world's first fully integrated bionic arm prosthesis that is ready to use - in keeping with the motto "Plug and Play".
In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
The World Health Organization (WHO) is attempting to clarify from China, reports that the government there encouraged farmers to use a human anti-viral drug to treat birds infected with a deadly strain of avian flu.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Elizabeth Speeker-cruit, MD 1717 N E St, Suite 430, Pensacola, FL 32501-6339 Ph: (850) 437-8711 | Margaret Elizabeth Speeker-cruit, MD 1717 N E St, Suite 430, Pensacola, FL 32501-6339 Ph: (850) 437-8711 |
News Archive
Next milestone in the development of bionic arm prostheses with major contribution from the Medical University of Vienna: in collaboration with the Massachusetts Institute of Technology (Center for Extreme Bionics) and the Department of Electrical Engineering at the University of Gothenburg, Oskar Aszmann's team in the Clinical Laboratory for Bionic Limb Reconstruction at MedUni Vienna's Department of Surgery has developed the world's first fully integrated bionic arm prosthesis that is ready to use - in keeping with the motto "Plug and Play".
In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
The World Health Organization (WHO) is attempting to clarify from China, reports that the government there encouraged farmers to use a human anti-viral drug to treat birds infected with a deadly strain of avian flu.
› Verified 7 days ago
Ashley B. King, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 | |
Dr. Alexander Liu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 Fax: 850-434-2647 | |
Dr. Kevin Gerald Mahaffey, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6000 W Highway 98, Naval Hospital Urology, Pensacola, FL 32512 Phone: 850-505-6485 | |
Dr. Anthony L Doerr, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, Urology Dept, Pensacola, FL 32514 Phone: 850-474-8398 Fax: 850-969-2962 | |
Dr. Ryan Keith Miyamoto, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1717 N E St, 430, Pensacola, FL 32501 Phone: 850-437-8711 | |
Robert A. Mevorach, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5153 N 9th Ave, Pensacola, FL 32504 Phone: 850-505-4700 | |
Dr. Spencer Land, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1549 Airport Blvd Ste 200f, Pensacola, FL 32504 Phone: 850-416-1950 Fax: 850-416-1951 |